Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1108 | 1014 | 1108 | 1161 | 1561 | 2805 |
Fund Return | 10.85% | 1.37% | 10.85% | 5.1% | 9.32% | 10.86% |
Place in category | 1628 | 1459 | 1628 | 1010 | 615 | 103 |
% in Category | 92 | 78 | 92 | 66 | 51 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 7.35B | 9.50 | 3.82 | 9.51 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.35B | 10.86 | 5.10 | 10.87 | ||
Manulife Glbl Eq Cl Sr T6 | 7.35B | 9.50 | 3.81 | 9.50 | ||
Manulife Div incm Fd Sr F | 6.83B | 16.41 | 2.59 | 9.90 | ||
Manulife Div incm Fd Sr T6 | 6.83B | 15.12 | 1.45 | 8.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.83B | 60.55 | 18.32 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.89B | 28.47 | 5.35 | 11.90 | ||
Capital Group Glbal Equity Fd A CAD | 13.89B | 27.06 | 4.20 | 10.67 | ||
Capital Group Glbal Equity Fd D CAD | 13.89B | 28.08 | 5.00 | 11.43 | ||
Mawer Global Equity | 13.75B | 10.72 | 4.79 | 10.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.29 | 100.30 | +0.10% | |
Marsh McLennan | US5717481023 | 5.01 | 217.43 | +0.04% | |
UnitedHealth | US91324P1021 | 4.41 | 529.77 | +1.93% | |
Microsoft | US5949181045 | 4.21 | 446.71 | +0.11% | |
Alimentation Couche Tard | CA01626P1484 | 4.03 | 76.75 | +0.56% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review